Evidence map›Paper›PMID 32620996›Full record

ArticleJournal of clinical immunology2020

Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect.

Khusan Khodzhaev, Sema Buyukkapu Bay, Rejin Kebudi, Didem Altindirek, Aysenur Kaya, Yucel Erbilgin, Ozden Hatirnaz Ng, Ayca Kiykim, Funda Cipe Erol, Feride Sen Zengin and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Genetic lesions and targeted therapy in Hodgkin lymphoma.Therapeutic advances in hematology · 2023
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Khusan KhodzhaevAziz Sancar Institute of Experimental Medicine, Genetics Department, Istanbul University, Istanbul, Turkey.
Sema Buyukkapu BayOncology Institute, Division of Pediatric Hematology-Oncology, Istanbul University, Istanbul, Turkey.
Rejin KebudiOncology Institute, Division of Pediatric Hematology-Oncology, Istanbul University, Istanbul, Turkey. rejinkebudi@yahoo.com.ORCID 0000-0003-4344-8174
Didem AltindirekAziz Sancar Institute of Experimental Medicine, Genetics Department, Istanbul University, Istanbul, Turkey.
Aysenur KayaFaculty of Medicine, Department of Pediatric Allergy Immunology, Istinye University, Istanbul, Turkey.
Yucel ErbilginAziz Sancar Institute of Experimental Medicine, Genetics Department, Istanbul University, Istanbul, Turkey.
Ozden Hatirnaz NgDepartment of Medical Biology, Acıbadem Mehmet Ali Aydınlar University School of Medicine, Istanbul, Turkey.
Ayca KiykimFaculty of Medicine, Division of Pediatric Allergy Immunology, Istanbul University Cerrahpasa, Istanbul, Turkey.
Funda Cipe ErolFaculty of Medicine, Department of Pediatric Allergy Immunology, Istinye University, Istanbul, Turkey.
Feride Sen ZenginIntensive Care Unit, Erzurum Education and Research Hospital, Erzurum, Turkey.
Sinem FirtinaFaculty of Art and Science, Department of Molecular Biology and Genetics, Istinye University, Istanbul, Turkey.
Yuk Yin NgGenetics and Bioengineering Department, Istanbul Bilgi University, Istanbul, Turkey.
Basak Adakli AksoyDepartment of Pediatric Hematology Oncology, Altınbaş University, Istanbul, Turkey.
Muge SayitogluAziz Sancar Institute of Experimental Medicine, Genetics Department, Istanbul University, Istanbul, Turkey.
Istanbul University · TRIstinye University · TRAltınbaş University · TRErzurum Regional Training and Research Hospital · TRIstanbul Bilgi University · TRIstanbul University-Cerrahpaşa · TRKent Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide sequencing studies in pediatric cancer cohorts indicate that about 10% of patients have germline mutations within cancer predisposition genes. Within this group, primary immune deficiencies take the priority regarding the vulnerability of the patients to infectious agents and the difficulties of cancer management. On the other hand, early recognition of these diseases may offer specific targeted therapies and hematopoietic stem cell transplantation as an option. Besides therapeutic benefits, early diagnosis will provide genetic counseling for the family members. Within this context, an extended family with multiple consanguineous marriages and affected individuals, who presented with combined immune deficiency (CID) and/or Hodgkin lymphoma phenotype, were examined by exome sequencing. A pathogenic homozygous missense CD70 variation was detected (NM_001252.5:c332C>T) in concordance with CD70 phenotype and familial segregation was confirmed. CD70 variations in patients with CID and malignancy have very rarely been reported. This paper reports extended family with multiple affected members with CID and malignancy carrying a missense CD70 variation, and reviews the rare cases reported in the literature. Primary immune deficiencies appear to be a potential cause for pediatric cancers. Better focusing on these inborn disorders to prevent or make an early diagnosis of malignant transformation and reduce mortalities is important.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseLymphomaOncogenesAntigen-Presenting CellsBiomarkers, TumorCD27 LigandConsanguinityGerm-Line MutationHigh-Throughput Screening AssaysHumansPedigreeSequence DeletionT-LymphocytesBiomarkers, TumorCD27 LigandCD70 protein, humanCD70EBVimmune deficiencylymphomamalignancies

Identifiers

PMID32620996
OpenAlexW3038592318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.